Laser Resurfacing Boca Raton: What the Evidence Says About Skin Type

Laser resurfacing Boca Raton patients consider is really two different treatments wearing one name. Ablative and non-ablative devices differ in recovery, in result, and most of all in the risk of leaving pigment behind. In a population as varied as South Florida’s, that last difference is the one that should drive the plan.

What a resurfacing laser is cleared to do

Two clearances show the range. The Lumenis UltraPulse CO₂ system, cleared December 2020 under K203544, is indicated for “surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue,” and its dermatology list does explicitly include laser skin resurfacing and treatment of wrinkles, rhytids and furrows.

Worth knowing what kind of document that is, though. The same clearance spans podiatry, ENT, gynaecology, neurosurgery, orthopaedics and dental surgery. The clearance that permits laser skin resurfacing also permits acoustic neuroma resection. A 510(k) here is a broad tissue-effect authorisation, not a finding that the device produces a particular cosmetic result.

The non-ablative side is narrower still. Clear + Brilliant Touch, cleared December 2022 under K223647, reads in full: “indicated for use in dermatological procedures requiring the coagulation of soft tissue and general skin resurfacing procedures.” No wrinkles, no melasma, no acne scars, no pores, no tone. Notably, it also carries no Fitzpatrick restriction.

The pigmentation question, reported as the literature reports it

This is the part of resurfacing where med-spa content is least reliable, because there is no single number to quote and most pages quote one anyway.

A systematic review of post-inflammatory hyperpigmentation after CO₂ laser, covering 14 prospective studies and 313 participants, states the position bluntly: “the overall incidence of PIH after CO₂ laser treatment significantly varies between the studies, ranging from 0% to 100%.” More surprisingly, it found that “the difference in PIH incidence based on skin type was not significant in any study.”

An evidence-based review of non-ablative fractional resurfacing in skin of colour reports individual figures that show where the variation comes from:

Read down that right-hand column and the pattern is clear. The spread is not noise; it tracks depth and density. The review’s own mechanistic conclusion is the sentence worth carrying into a consultation: “treatment density is a stronger factor than energy in determining PIH development.”

So the defensible statement, and the only one we will make, is this: pigmentation change is the dominant complication of resurfacing, published rates span the full range depending on device, density and protocol, ablative carries substantially more risk than non-ablative, and anyone quoting you a single percentage is not reading the literature.

Choosing the device around your skin, not the other way round

The evidence-based review of skin of colour concludes that “the available evidence strongly suggests that fractional lasers are a favorable treatment option” across a range of dermatological conditions, with Level 1b evidence for acne and striae and Level 2b for acne scars and melasma. It then adds the qualifier that shapes practice: “ablative fractional lasers are usually associated with greater efficacy but longer recovery time and higher risk of complications in SPT IV to VI.”

That is the trade-off in one sentence. More aggressive treatment does more, and risks more, and the risk rises with skin tone. For Fitzpatrick IV and above the sensible default is non-ablative fractional at a conservative density, with the option to escalate once the skin has shown how it responds — rather than the reverse.

Priming matters too. The prevention data are encouraging and specific: in the CO₂ review, platelet-rich plasma was associated with a 16% pigmentation rate and clobetasol propionate 0.05% with 39%, against rates above 50% for several other regimens. Pre-treatment is not an upsell here; it is one of the few variables shown to change the outcome.

Recovery, and the complications worth knowing about

A review of fractional CO₂ complications gives a useful picture of modern devices against their predecessors. Temporary hyperpigmentation, it notes, was “so common following previous generation CO₂ lasers in skin types IV and V” and is less likely with fractional resurfacing. Delayed permanent hypopigmentation, seen in up to 19% of cases with older CO₂ lasers, is described as “very uncommon” with fractionated devices. Prolonged erythema, also common historically, is now uncommon.

Scarring is rare and, importantly, largely preventable: the cases documented in that review were caused by infection. Acne and milia are described as common minor effects that resolve on their own. The lower eyelid carries a specific risk of ectropion, particularly after previous blepharoplasty, which is a reason the assessment matters as much as the settings.

On timing, the same review flags the obvious South Florida problem directly: “patients who tan easily may be at risk for hyperpigmentation after their laser session.” Resurfacing and sun are a poor combination in both directions, and scheduling around that is part of the plan rather than an afterthought.

Where pigment or redness rather than texture is the main concern, the IPL photofacial page covers the better-matched option, and the skin and laser section of the services page sets out the rest.

Frequently asked questions

Sources and how this page was built

Clearance language was read from FDA 510(k) records K203544 and K223647 on 26 September 2026 and is quoted as cleared. Pigmentation and complication figures are taken from the systematic reviews cited and are reported as ranges where the sources report ranges. Where two primary sources disagree, both are given. Single-figure complication rates in wide circulation could not be traced and are not repeated.

Why patients choose Brazelia MedSpa

The reason this page publishes a range instead of a reassuring percentage is that the range is what the evidence supports. A clinic willing to tell you that pigmentation rates run from nothing to everything depending on how the device is set is a clinic that is going to set it carefully.

Laser resurfacing in Boca Raton is planned here around your skin type first and the device second, with conservative density as the default in deeper phototypes and the option to escalate once we have seen how your skin responds. Pre-treatment priming is discussed because the data say it changes outcomes, not because it adds a line to the bill.

Brazelia MedSpa has treated patients from the same address in downtown Boca Raton for 18 years, near Mizner Park, and serves patients across South Florida, from Delray Beach and Boynton Beach to Deerfield Beach and Fort Lauderdale. In a field where med spas open and close within a season, staying in one place that long is its own kind of evidence. Patients rate the practice 4.5 out of 5 across 24 Google reviews.

A face is also rarely treated as just a face here. Because Brazelia MedSpa runs hormone, metabolic, skin and regenerative programmes under one roof, a treatment plan can take account of what else is going on — skin quality, weight change, hormonal shifts — instead of being sold in isolation. Where that is relevant to you it comes up at the consultation. Where it is not, nobody raises it.

New patients start with a consultation, and nothing is treated on a first visit unless you want it to be. You will hear what the approved labelling actually supports before you hear what it costs.

This page describes what published labels, regulatory records and peer-reviewed research report about these treatments. It is general health information, not medical advice, and it is not a substitute for a consultation. Whether any treatment is appropriate for you is a clinical judgement that depends on your history and examination.